They expressed hopes that through the forum, they could enhance exchanges and mutual learning, deepen innovative ...

Fintel reports that on April 4, 2025, Maxim Group downgraded their outlook for ... Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic ...

Issued 12,765,958 new sharesPriced at €2.35 per share, representing a 15.44% discount on the 5-day VWAPStrong investor demand, with the offering significantly oversubscribed€15 million anchored by a ...

ZD Jasper Realty secured a $125 million construction loan from iCross Capital for a 23-story, 190-unit luxury condo project ...

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced ...

We recently published a list of 13 Best Precious Metals Stocks to Buy According to Analysts. In this article, we are going to ...

Rezolute (RZLT) announced the pricing of an underwritten offering, priced at-the-market under Nasdaq rules, of an aggregate of 20,786,923 ...

NioCorp Developments Ltd. (”NioCorp” or the “Company”) (NASDAQ:NB) today announced the pricing of its previously announced ...

For his part, Russia’s Minister of Economic Development HE Maxim Reshetnikov said in his opening remarks that the ...

All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Rezolute. The closing of the offering is expected to occur on or about April 24, 2025, subject to the ...

Bournemouth managed to avoid breaching PSR rules after having a £71.4m shareholder loan write-off approved by the Premier League ...